Pharmacokinetic data and drug monitoring: I. Antibiotics and antiarrhythmics.
about
Pharmacokinetic considerations in the eradication of Helicobacter pylori.Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactionsPhosphonopeptides as antibacterial agents: metabolism and pharmacokinetics of alafosfalin in animals and humansEffects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.
P2860
Pharmacokinetic data and drug monitoring: I. Antibiotics and antiarrhythmics.
description
1975 nî lūn-bûn
@nan
1975 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
name
Pharmacokinetic data and drug monitoring: I. Antibiotics and antiarrhythmics.
@ast
Pharmacokinetic data and drug monitoring: I. Antibiotics and antiarrhythmics.
@en
type
label
Pharmacokinetic data and drug monitoring: I. Antibiotics and antiarrhythmics.
@ast
Pharmacokinetic data and drug monitoring: I. Antibiotics and antiarrhythmics.
@en
prefLabel
Pharmacokinetic data and drug monitoring: I. Antibiotics and antiarrhythmics.
@ast
Pharmacokinetic data and drug monitoring: I. Antibiotics and antiarrhythmics.
@en
P2860
P1476
Pharmacokinetic data and drug monitoring: I. Antibiotics and antiarrhythmics.
@en
P2093
P2860
P304
P356
10.1002/J.1552-4604.1975.TB02362.X
P577
1975-05-01T00:00:00Z